Diabetes Treatment
-

Breakthrough: Metformin’s Brain Mechanism Discovered
Scientists uncover how metformin impacts brain pathways to regulate blood sugar, opening doors to new diabetes treatments and aging research.
-

Novo Nordisk Boosts Oral GLP-1 Production Amid Intensifying Competition
Novo Nordisk commits €432 million to scale oral GLP-1 production in Ireland, solidifying its chronic disease treatment focus.
-

Eli Lilly Stock Surges After Record Q3 Earnings and Raised Guidance
Eli Lilly delivered a standout third quarter, beating Wall Street forecasts on both earnings and revenue, fueled by soaring demand for diabetes and obesity treatments. The company raised its full-year guidance, signaling strong growth momentum and investor confidence.

